KALA BIO, Inc. (KALA)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch KALA
See up to 3 months of KALA. The 7-day demo opens the 1M and 3M ranges and puts KALA on your watchlist.
Start 7-day demoLatest KALA insider trades
About KALA BIO, Inc. (KALA)
The SEC lists KALA BIO, Inc. under CIK 0001479419, in pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
KALA Form 4 activity by transaction type, last 90 days
No Form 4 activity for KALA in the last 90 days.
KALA insider transactions (Form 4)
2214 Form 4 filings on record, the earliest from Dec 31, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| David E. Lazar - Officer | Grant or award | Series AA Convertible Preferred Stock | 900,000 | - footnote F2 | - | |
| ||||||
| Darius Kharabi - Officer | Open-market sale | Common Stock | 20,806 | $0.83 footnote F1 | $17K | |
| ||||||
| Mary Reumuth - Officer | Open-market sale | Common Stock | 32,230 | $0.83 footnote F1 | $27K | |
| Mary Reumuth - Officer | Open-market sale | Common Stock | 967 | $0.82 | $793 | |
| ||||||
 Todd Bazemore | Open-market sale | Common Stock | 47,768 | $0.83 footnote F1 | $40K | |
| ||||||
| Mark T. Iwicki | Open-market sale | Common Stock | 154,894 | $0.81 footnote F1 | $125K | |
| ||||||
| Romulus K. Brazzell - Officer | Open-market sale | Common Stock | 46,748 | $0.83 footnote F1 | $39K | |
| ||||||
| BAKER BROS. ADVISORS LP | Open-market sale | Common Stock | 21,376 | $1.60 | $34K | |
| BAKER BROS. ADVISORS LP | Open-market sale | Common Stock | 195,425 | $1.60 | $312K | |
| BAKER BROS. ADVISORS LP | Open-market sale | Common Stock | 50,640 | $1.38 | $70K | |
| BAKER BROS. ADVISORS LP | Open-market sale | Common Stock | 462,967 | $1.38 | $641K | |
| Todd Bazemore - Officer | Grant or award | Stock Option (right to buy) | 180,000 | $0.00 | - | |
| Romulus K. Brazzell - Officer | Open-market sale | Common Stock | 5,251 | $4.01 | $21K | |
| Howard B. Rosen | Grant or award | Common Stock | 2,450 | $0.00 | - | |
| Howard B. Rosen | Grant or award | Stock Option (right to buy) | 5,450 | $0.00 | - | |
 Andrew I. Koven | Grant or award | Common Stock | 3,050 | $0.00 | - | |
| Andrew I. Koven | Grant or award | Stock Option (right to buy) | 6,850 | $0.00 | - | |
| Gregory D. Perry | Grant or award | Common Stock | 2,450 | $0.00 | - | |
| Gregory D. Perry | Grant or award | Stock Option (right to buy) | 5,450 | $0.00 | - | |
| Romulus K. Brazzell - Officer | Open-market sale | Common Stock | 3,687 | $3.74 | $14K | |
| BAKER BROS. ADVISORS LP | Open-market purchase | Common Stock | 30,620 | $6.44 | $197K | |
| BAKER BROS. ADVISORS LP | Open-market purchase | Common Stock | 279,939 | $6.44 | $1.80M | |
Item 1.01, 9.01
Item 5.08, 8.01
Item 3.01
Item 8.01, 9.01
KALA insider trading FAQ
What is the latest insider trade for KALA?
KALA BIO, Inc. (KALA) has filed no insider reports in the last 90 days. The most recent on record is dated 2025-11-26. The full record for KALA runs to 14 Form 4 filings, the earliest from 2024-12-31. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying KALA stock?
No insider purchases of KALA were filed in the last 90 days. 2 purchases are on record for this company.
How many insiders are selling KALA stock?
No insider sales of KALA were filed in the last 90 days. 12 sales are on record for this company.
Where can I see KALA SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects KALA Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - David E. Lazar view on EDGAR
- - Darius Kharabi view on EDGAR
- - Mary Reumuth view on EDGAR
- - Todd Bazemore view on EDGAR
- - Mark T. Iwicki view on EDGAR
- - Romulus K. Brazzell view on EDGAR
- - BAKER BROS. ADVISORS LP view on EDGAR
- - Todd Bazemore view on EDGAR
- - Romulus K. Brazzell view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where KALA's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow KALA with a 7-day demo
- KALA on your watchlist
- Every KALA Form 4 filing on record
- Up to 3 months of KALA price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
